Jennison Associates LLC Takes $20.74 Million Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jennison Associates LLC bought a new position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund bought 582,764 shares of the medical instruments supplier's stock, valued at approximately $20,741,000. Jennison Associates LLC owned 0.28% of DENTSPLY SIRONA as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also modified their holdings of XRAY. VisionPoint Advisory Group LLC raised its stake in DENTSPLY SIRONA by 104.2% in the 3rd quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier's stock worth $26,000 after purchasing an additional 395 shares in the last quarter. Anchor Investment Management LLC acquired a new stake in DENTSPLY SIRONA in the 4th quarter worth about $47,000. Exchange Traded Concepts LLC raised its stake in DENTSPLY SIRONA by 41.2% in the 3rd quarter. Exchange Traded Concepts LLC now owns 1,504 shares of the medical instruments supplier's stock worth $51,000 after purchasing an additional 439 shares in the last quarter. Creative Financial Designs Inc. ADV acquired a new position in shares of DENTSPLY SIRONA in the 4th quarter valued at approximately $71,000. Finally, CWM LLC raised its position in shares of DENTSPLY SIRONA by 85.5% in the 3rd quarter. CWM LLC now owns 4,379 shares of the medical instruments supplier's stock valued at $150,000 after buying an additional 2,018 shares in the last quarter. Institutional investors own 95.70% of the company's stock.

DENTSPLY SIRONA Trading Up 0.7 %

XRAY traded up $0.22 during trading on Friday, reaching $30.57. 1,158,487 shares of the company's stock were exchanged, compared to its average volume of 3,324,788. DENTSPLY SIRONA Inc. has a one year low of $26.27 and a one year high of $43.24. The company has a current ratio of 1.38, a quick ratio of 0.95 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $6.34 billion, a PE ratio of -48.95, a price-to-earnings-growth ratio of 1.25 and a beta of 0.98. The firm has a fifty day moving average price of $32.59 and a two-hundred day moving average price of $32.78.

DENTSPLY SIRONA (NASDAQ:XRAY - Get Free Report) last posted its earnings results on Thursday, February 29th. The medical instruments supplier reported $0.44 earnings per share for the quarter, topping analysts' consensus estimates of $0.43 by $0.01. DENTSPLY SIRONA had a negative net margin of 3.33% and a positive return on equity of 11.14%. The firm had revenue of $1.01 billion for the quarter, compared to analyst estimates of $972.61 million. During the same period in the previous year, the firm posted $0.46 EPS. The company's revenue for the quarter was up 3.0% compared to the same quarter last year. As a group, equities research analysts forecast that DENTSPLY SIRONA Inc. will post 2.05 earnings per share for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 12th. Shareholders of record on Friday, March 29th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 2.09%. This is a positive change from DENTSPLY SIRONA's previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. DENTSPLY SIRONA's payout ratio is presently -103.22%.

Wall Street Analysts Forecast Growth

XRAY has been the subject of several analyst reports. Needham & Company LLC restated a "buy" rating and issued a $42.00 target price on shares of DENTSPLY SIRONA in a research report on Thursday, February 29th. SVB Leerink initiated coverage on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. They issued an "outperform" rating and a $42.00 target price for the company. Barrington Research restated an "outperform" rating and issued a $41.00 target price on shares of DENTSPLY SIRONA in a research report on Thursday, April 18th. Piper Sandler upped their price objective on shares of DENTSPLY SIRONA from $31.00 to $35.00 and gave the stock a "neutral" rating in a research report on Friday, January 12th. Finally, Leerink Partnrs reiterated an "outperform" rating on shares of DENTSPLY SIRONA in a research report on Monday, February 26th. Three investment analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of "Moderate Buy" and an average price target of $39.50.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.